Drug-Eluting Stents Appear Superior to Bare Metal Stents for Vein-Graft PCI in Vessels up to a Stent Diameter of 4 mm-Reference-Cited by-同舟云学术

Drug-Eluting Stents Appear Superior to Bare Metal Stents for Vein-Graft PCI in Vessels up to a Stent Diameter of 4 mm

Published:2016-01 Issue:1 Volume:11 Page:heartint.500022
ISSN:1826-1868
Container-title:Heart International
language:en
Short-container-title:Heart International

Author:

Guttmann Oliver P.¹,Jones Daniel A.¹²³,Safwan Kassem A.¹,Gallagher Sean¹,Rathod Krishnaraj S.¹²³,Hamshere Steve¹²³,Smith Elliot J.¹,Jain Ajay K.¹²³,Mathur Anthony¹²³,Wragg Andrew¹³,Knight Charles J.¹³,Weerackody Roshan¹³

Affiliation:

1. Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK

2. Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK

3. NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK

Publisher

Touch Medical Media, Ltd.

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.5301/heartint.5000228

Reference25 articles.

1. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

2. Comparison of Five-Year Outcome of Octogenarians Undergoing Percutaneous Coronary Intervention With Drug-Eluting Versus Bare-Metal Stents (from the RESEARCH and T-SEARCH Registries)

3. Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation

4. Drug-Eluting or Bare Metal Stents for the Treatment of Saphenous Vein Graft Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Debulking strategies in revascularization of diseased saphenous vein bypass grafts;Debulking in Cardiovascular Interventions and Revascularization Strategies;2022

2. Joint effect of platelet distribution width and stent surface area on major adverse cardiovascular events after percutaneous coronary intervention;Annals of Palliative Medicine;2021-05

3. The Spectrum of Clinical Presentations and Management Options for the Treatment of Degenerative Atherothrombotic Disease of Saphenous Vein Grafts;Cardiovascular Thrombus;2018